Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CAPECITABINE Cause Peripheral sensory neuropathy? 192 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 192 reports of Peripheral sensory neuropathy have been filed in association with CAPECITABINE (Capecitabine). This represents 0.3% of all adverse event reports for CAPECITABINE.

192
Reports of Peripheral sensory neuropathy with CAPECITABINE
0.3%
of all CAPECITABINE reports
25
Deaths
33
Hospitalizations

How Dangerous Is Peripheral sensory neuropathy From CAPECITABINE?

Of the 192 reports, 25 (13.0%) resulted in death, 33 (17.2%) required hospitalization, and 8 (4.2%) were considered life-threatening.

Is Peripheral sensory neuropathy Listed in the Official Label?

Yes, Peripheral sensory neuropathy is listed as a known adverse reaction in the official FDA drug label for CAPECITABINE.

What Other Side Effects Does CAPECITABINE Cause?

Diarrhoea (9,277) Nausea (6,248) Palmar-plantar erythrodysaesthesia syndrome (5,294) Fatigue (5,018) Death (4,422) Vomiting (4,111) Disease progression (3,808) Off label use (3,193) Malignant neoplasm progression (2,425) Asthenia (2,352)

What Other Drugs Cause Peripheral sensory neuropathy?

PACLITAXEL (554) OXALIPLATIN (510) DEXAMETHASONE (435) CYCLOPHOSPHAMIDE (407) BEVACIZUMAB (382) DOXORUBICIN (358) FLUOROURACIL (345) CARBOPLATIN (332) VINCRISTINE (295) BORTEZOMIB (290)

Which CAPECITABINE Alternatives Have Lower Peripheral sensory neuropathy Risk?

CAPECITABINE vs CAPIVASERTIB CAPECITABINE vs CAPLACIZUMAB CAPECITABINE vs CAPLACIZUMAB-YHDP CAPECITABINE vs CAPMATINIB CAPECITABINE vs CAPREOMYCIN

Related Pages

CAPECITABINE Full Profile All Peripheral sensory neuropathy Reports All Drugs Causing Peripheral sensory neuropathy CAPECITABINE Demographics